If you have Medicare and are thinking of switching plans in 2027, you can now see how well the government rates each option. The Centers for Medicare and Medicaid Services (CMS) published the October 8 star ratings for 2027 Medicare Advantage and prescription drug plans (Part D).

Why it matters: according to CMS, the star ratings help people with Medicare and their caregivers compare the quality of plans along with their benefits and costs, and choose the option that best fits their health needs.

CMS rates plans based on the quality of health and drug services received by their members.

For 2027, CMS added new measures, such as one on the concurrent use of opioids and benzodiazepines, and another on the use of multiple anticholinergic medications for older adults.

Medicare Advantage with drug coverage:

Prescription drug plans (Part D):

In the plan finder, contracts with five stars display a high-performance icon. In contrast, four Medicare Advantage plans with drug coverage display a low-performance icon due to consistently low ratings. This is the same number as last year.

If your plan has this icon, it's worth reviewing other options before open enrollment ends.

Source: CMS, fact sheet «2027 Medicare Advantage and Part D Star Ratings», October 8, 2026.